Top Markets
Coin of the day
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

600329
Rang in aandelen #5093
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
Aandeelprijs
$5.25
Marktkapitalisatie
$2.99B
Verandering (1 dag)
-0.93%
Verandering (1 jaar)
-13.47%
Land
CN
Handel Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)

Categorie

Prijs 600329 met de marktkapitalisatie van B
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329
$5.25
Marktkapitalisatie van Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited(600329)
Marktkapitalisatie: $2.99B
Vanaf August 2026 heeft Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited een marktkapitalisatie van $2.99B. Dit maakt Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited volgens onze gegevens het 5093rd meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited van 2001 tot 2026
600329 vergeleken met de top 5 populairste stocks
Prijs voor 600329 Aandeel B Marktkapitalisatie van B uitslagen
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
$8,924.60 $2.99B
$5.088T +169,838.00%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
$8,119.86 $2.99B
$4.629T +154,514.58%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
$7,222.65 $2.99B
$4.118T +137,430.25%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
$6,466.84 $2.99B
$3.687T +123,038.60%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
$4,910.84 $2.99B
$2.800T +93,409.92%